XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Beginning Balance at Dec. 31, 2020 $ 1,910,528 $ 7,175 $ 314,056 $ (756,842) $ 2,335,216 $ 10,923
Beginning balance (in shares) at Dec. 31, 2020   100,447        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 72,293       72,297 (4)
Other comprehensive income/(loss):            
Translation gain/(loss) (32,541)     (32,021)   (520)
Defined benefit plan adjustment, net of tax 5,385     5,385    
Derivative financial instruments, net of tax 958     958    
Other comprehensive income/(loss) (26,198)     (25,678)   (520)
Dividends (45,510)       (45,510)  
Issuance of stock awards 364   364      
Issuance of stock awards (in shares)   245        
Shares repurchased (5,051)   (5,051)      
Shares repurchased (in shares)   (85)        
Stock-based compensation 6,372   6,372      
Ending Balance at Apr. 04, 2021 1,912,798 $ 7,175 315,741 (782,520) 2,362,003 10,399
Ending balance (in shares) at Apr. 04, 2021   100,607        
Beginning Balance at Dec. 31, 2021 $ 1,849,541 [1] $ 7,175 119,690 (359,425) 2,070,005 12,096
Beginning balance (in shares) at Dec. 31, 2021 97,370 97,370        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 115,607       115,333 274
Other comprehensive income/(loss):            
Translation gain/(loss) 706     (185)   891
Defined benefit plan adjustment, net of tax 191     191    
Derivative financial instruments, net of tax 2,550     2,550    
Other comprehensive income/(loss) 3,447     2,556   891
Dividends (44,124)       (44,124)  
Purchase of noncontrolling interest (13,196)   (7,080)     (6,116)
Issuance of stock awards 377   377      
Issuance of stock awards (in shares)   182        
Shares repurchased (3,410)   (3,410)      
Shares repurchased (in shares)   (60)        
Stock-based compensation 10,689   10,689      
Ending Balance at Apr. 03, 2022 $ 1,918,931 $ 7,175 $ 120,266 $ (356,869) $ 2,141,214 $ 7,145
Ending balance (in shares) at Apr. 03, 2022 97,492 97,492        
[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.